Choong Ang Vaccine Laboratory Co. Ltd
Choong Ang Vaccine Laboratory Co., Ltd. engages in the research, development, manufacturing, and sale of animal vaccines in South Korea, Asia, Africa, and the United States. It offers swine, poultry, cattle, canine, feline, wild boar, and raccoon vaccines under the SuiShot, PoulShot, BoviShot, CaniShot, and FeliShot brands. The company was founded in 1968 and is headquartered in Daejeon, South Ko… Read more
Market Cap & Net Worth: Choong Ang Vaccine Laboratory Co. Ltd (072020)
Choong Ang Vaccine Laboratory Co. Ltd (KQ:072020) has a market capitalization of $59.00 Million (₩86.38 Billion) as of March 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #22262 globally and #1121 in its home market, demonstrating a 2.10% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Choong Ang Vaccine Laboratory Co. Ltd's stock price ₩9230.00 by its total outstanding shares 9358687 (9.36 Million).
Choong Ang Vaccine Laboratory Co. Ltd Market Cap History: 2015 to 2026
Choong Ang Vaccine Laboratory Co. Ltd's market capitalization history from 2015 to 2026. Data shows change from $79.73 Million to $59.00 Million (-3.24% CAGR).
Index Memberships
Choong Ang Vaccine Laboratory Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.85 Billion | 0.02% | #535 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.85 Billion | 0.02% | #535 of 1384 |
Weight: Choong Ang Vaccine Laboratory Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Choong Ang Vaccine Laboratory Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Choong Ang Vaccine Laboratory Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Choong Ang Vaccine Laboratory Co. Ltd's market cap is 0.00 times its annual revenue
1.12x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.01x
Choong Ang Vaccine Laboratory Co. Ltd's market cap is 0.01 times its annual earnings
12.07x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $79.73 Million | $34.60 Billion | $3.25 Billion | 0.00x | 0.02x |
| 2016 | $121.47 Million | $37.90 Billion | $6.21 Billion | 0.00x | 0.02x |
| 2017 | $85.63 Million | $31.87 Billion | $4.58 Billion | 0.00x | 0.02x |
| 2018 | $102.78 Million | $33.15 Billion | $3.45 Billion | 0.00x | 0.03x |
| 2019 | $111.77 Million | $32.90 Billion | $1.85 Billion | 0.00x | 0.06x |
| 2020 | $107.25 Million | $36.32 Billion | $3.16 Billion | 0.00x | 0.03x |
| 2021 | $94.15 Million | $40.91 Billion | $7.60 Billion | 0.00x | 0.01x |
| 2022 | $69.67 Million | $39.30 Billion | $4.04 Billion | 0.00x | 0.02x |
| 2023 | $70.37 Million | $41.87 Billion | $6.00 Billion | 0.00x | 0.01x |
| 2024 | $62.64 Million | $45.59 Billion | $6.85 Billion | 0.00x | 0.01x |
Competitor Companies of 072020 by Market Capitalization
Companies near Choong Ang Vaccine Laboratory Co. Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Choong Ang Vaccine Laboratory Co. Ltd by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Choong Ang Vaccine Laboratory Co. Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Choong Ang Vaccine Laboratory Co. Ltd's market cap moved from $79.73 Million to $ 59.00 Million, with a yearly change of -3.24%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩59.00 Million | -5.82% |
| 2025 | ₩62.64 Million | 0.00% |
| 2024 | ₩62.64 Million | -10.99% |
| 2023 | ₩70.37 Million | +1.01% |
| 2022 | ₩69.67 Million | -26.00% |
| 2021 | ₩94.15 Million | -12.22% |
| 2020 | ₩107.25 Million | -4.05% |
| 2019 | ₩111.77 Million | +8.74% |
| 2018 | ₩102.78 Million | +20.03% |
| 2017 | ₩85.63 Million | -29.50% |
| 2016 | ₩121.47 Million | +52.35% |
| 2015 | ₩79.73 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Choong Ang Vaccine Laboratory Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $59.00 Million USD |
| MoneyControl | $59.00 Million USD |
| MarketWatch | $59.00 Million USD |
| marketcap.company | $59.00 Million USD |
| Reuters | $59.00 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.